NCT00428220 2019-06-27A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.PfizerPhase NA Completed223 enrolled 8 charts
NCT02273752 2017-02-03Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerEmory UniversityPhase 2 Terminated2 enrolled 5 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts